Polycystic ovary syndrome is a widespread reproductive disorder causing up to 30% of infertility in couples seeking treatment, with an unclear etiology and no current cure.
This review discusses the current status, etiology, and future perspectives of polycystic ovary syndrome, highlighting its association with metabolic and cardiovascular risks.
Polycystic ovary syndrome (PCOS) is a widespread reproductive disorder that encompasses many associated health conditions and has an impact on various metabolic processes. PCOS is depicted by hyperandrogenism, polycystic ovaries, and anovulation. It increases the risk of insulin resistance (IR), type 2 diabetes, obesity, and cardiovascular disease. The etiology of the disease remains unclear, and the subjective phenotype makes a united diagnosis difficult among physicians. It seems to be a familial genetic syndrome caused by a combination of environmental and genetic factors. It can be linked with metabolic disorders in first-degree family members. PCOS is the cause of up to 30% of infertility in couples seeking treatment. Currently, there is no cure for PCOS. Despite the growing incidence of this syndrome, limited research has been done that encompasses the entirety of PCOS spectrum. In this review, the current status and possible future perspective will be discussed.
Rajesh K. Naz (2014) conducted a review in Polycystic ovary syndrome (PCOS). Polycystic ovary syndrome is a widespread reproductive disorder causing up to 30% of infertility in couples seeking treatment, with an unclear etiology and no current cure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: